Step-brothers in arms, SAGA and ATAC co-activator complexes, use different strategies.

SAGA and ATAC co-activator complexes use different strategies, with distinct interactions and chromatin-reading capabilities, to regulate gene transcription in cancer cells.

• Why it matters: Understanding how these complexes differ is crucial because their dysregulation can contribute to cancer progression, and targeting them may offer new therapeutic options.
• What they did: The review synthesizes evidence on the specific interactions of transcriptional activators with SAGA or ATAC, their recognition of histone modifications, and their roles in gene regulation and oncogenesis.
• The result: This knowledge advances the potential for developing small-molecule inhibitors that disrupt SAGA or ATAC activity, providing promising strategies for precision oncology.